Articles tagged with Liver Cancer
A double-blind study conducted in China found that chlorophyllin supplements reduced DNA damage related to aflatoxin exposure in healthy adults. The study showed a 55% reduction in aflatoxin damage, which could lead to a lower risk of liver cancer.
Researchers found that taking chlorophyllin three times a day reduced aflatoxin-DNA damage by 55 percent among residents of Qidong, China. The study suggests that chlorophyllin may act as an 'interceptor molecule' to block the absorption of aflatoxins and carcinogens in the diet.
A team of researchers has shown that oltipraz, a chemopreventive agent, can alter the disposition of aflatoxin in people at high risk for liver cancer. The study establishes proof of principle that chemo-preventive agents can work by changing the metabolism of environmental carcinogens.
New research suggests that prolonged alcohol intake can lead to cancer risk due to acetaldehyde production, which damages genetic building blocks and is efficiently inserted into DNA in some people. A large percentage of Asians lack the enzyme needed to break down acetaldehyde, making them more prone to esophageal and liver cancers.
Researchers are developing a new alternative treatment for cancer using radio-frequency ablation, which heats diseased cells with a fine electrode. The technique has shown promising results in treating liver cancers, with nine out of twelve patients remaining cancer-free for more than a year.
Researchers at Duke University Medical Center found that a hepatitis infection converts the liver into a 'cancer time bomb' by converting it into billions of cancer-prone cells. The virus makes even apparently healthy cells lose one of two copies of a protective tumor suppressor gene, making them vulnerable to further genetic damage.
A team of physicians from Memorial Sloan-Kettering Cancer Center and the University of Rochester's Cancer Center have developed a herpes-based gene therapy that recruits the immune system to target and eliminate cancer cells in the liver. The vaccine has shown promising results, with laboratory rats achieving complete remission and few...
A promising hepatitis-based gene therapy has been developed to target and eliminate liver cancer cells. The treatment, created by a team of physicians, recruits the body's immune system to attack and wipe out cancerous tumors.
Researchers discovered that a malfunctioning gene, M6P/IGF2r, acts as a tumor suppressor in human liver tumors. The gene's loss or mutation may predispose cells to cancerous growth, leading to the formation of liver cancer. This finding could lead to the development of early diagnostic tests and new treatments for the disease.